当前位置：首页 > 文献互助 > 互助详情

Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma复制

用户kXbnTIWMyBRM 1小时前 15 10 待确认 帖子自动结束时间: 2026-02-09 16:08:55

1. 请及时下载文件确认是否正确, 系统将在 2026-02-11 16:19:19 删除文件

2. 如若文件有误请驳回应助文件, 求助状态即回到求助中

3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1158/1078-0432.CCR-24-0473复制

文献链接: https://aacrjournals.org/clincancerres/article/30/17/3726/747260/Eftilagimod-Alpha-Soluble-LAG3-Protein-Combined复制

其他信息:

出版社: American Association for Cancer Research (AACR)
作者: Martin Forster; Irene Brana; Antonio L. Pousa; Bernard Doger; Patricia Roxburgh; Pawan Bajaj; Julio Peguero; Matthew Krebs; Enric Carcereny; Grisma Patel; Christian Mueller; Chrystelle Brignone; Frederic Triebel
全文下载地址: https://aacrjournals.org/clincancerres/article-pdf/doi/10.1158/1078-0432.CCR-24-0473/3474882/ccr-24-0473.pdf

上一篇：First-in-class casein kinase 1 alpha inhibitors for overcoming treatment related resistance in AML and pancreatic cancer

下一篇：Neoadjuvant immunotherapy and oncolytic virotherapy in HPV positive and HPV negative skin cancer: A comprehensive review

互助时间线

2026-02-04 16:19:19 [上传文件]

笑容灿烂上传了文件(pdf 2.08 MB), 求助状态变成 待确认

2026-02-04 16:08:55 [发起求助]

最新发布的求助

Depemokimab: a new long-acting anti-IL5 treatment for severe asthma and chronic rhinosinusitis with nasal polyps 1小时前
Depemokimab in chronic rhinosinusitis with nasal polyps: A turning point or a missed opportunity? 1小时前
[Pharmacokinetics of ferulic acid in transdermal delivery] 1小时前
P3.18.75 Tislelizumab in Combination With EP/EC Chemotherapy and Sequent Anlotinib Followed by Radiotherapy as First-Line Treatment for ES-SCLC 1小时前
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation 1小时前
A hydrophobic FeMn@Si catalyst increases olefins from syngas by suppressing C1 by-products 1小时前
Neoadjuvant immunotherapy and oncolytic virotherapy in HPV positive and HPV negative skin cancer: A comprehensive review 1小时前
Eftilagimod Alpha (Soluble LAG3 Protein) Combined with Pembrolizumab as Second-Line Therapy for Patients with Metastatic Head and Neck Squamous Cell Carcinoma 1小时前
First-in-class casein kinase 1 alpha inhibitors for overcoming treatment related resistance in AML and pancreatic cancer 1小时前
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) 2小时前
Chapter 17: Scale-Down Models for Robust Biologics Drug Product Process Development 2小时前
Quelet, Bulletin de la Societe Chimique de France, 1933, vol. <4> 53, p. 222,233 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com